What are common prenatal and perinatal tests, procedures, and imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Prenatal and Perinatal Testing, Procedures, and Imaging

Transabdominal and transvaginal ultrasound are the cornerstone of prenatal evaluation, with specific timing and indications for additional testing such as fetal echocardiography, Doppler studies, and genetic testing based on risk factors and gestational age. 1

First Trimester Testing (Weeks 1-13)

Ultrasound

  • Transabdominal and transvaginal ultrasound (10-14 weeks)
    • Confirms pregnancy location, viability, and dating
    • Evaluates for multiple gestations and determines chorionicity/amnionicity
    • Measures nuchal translucency (NT) at 11-13+6 weeks 1, 2
    • Documents embryonic/fetal cardiac activity

Genetic Screening

  • First trimester combined screening (11-13+6 weeks)
    • NT measurement plus maternal serum PAPP-A and free β-hCG
    • Detection rate ~85% for Down syndrome with 5% false-positive rate 2
  • Cell-free DNA (cfDNA) screening
    • 99% detection rate for trisomy 21 with 1-9% screen positive rate
    • Typically performed after 10 weeks 2

Diagnostic Testing

  • Chorionic villus sampling (CVS) (10-13 weeks)
    • Invasive diagnostic test for chromosomal abnormalities
    • Indicated for advanced maternal age, abnormal screening, family history 2, 3

Second Trimester Testing (Weeks 14-27)

Ultrasound

  • Anatomy scan (18-22 weeks)
    • Standard of care for all pregnancies 1
    • Evaluates fetal anatomy, growth, amniotic fluid, and placenta
    • May be performed 2 weeks later (20-22 weeks) in obese patients 1
  • Cervical length measurement (transvaginal)
    • Screens for risk of preterm birth
    • Particularly important in multiple gestations 1

Diagnostic Testing

  • Amniocentesis (15-20 weeks)
    • Invasive diagnostic test for chromosomal and genetic disorders
    • Indicated for advanced maternal age, abnormal screening, family history 2, 3

Specialized Testing

  • Fetal echocardiography (18-22 weeks)
    • Detailed evaluation of fetal cardiac structures
    • Indicated for maternal diabetes, family history of congenital heart disease, abnormal anatomy scan, multiple gestations (especially monochorionic) 1
  • Glucose tolerance test (24-28 weeks)
    • Screens for gestational diabetes 2

Third Trimester Testing (Weeks 28-40)

Growth Assessment

  • Serial growth ultrasounds (every 3-4 weeks from 28-32 weeks)
    • Monitors fetal growth
    • Particularly important in high-risk pregnancies (advanced maternal age, multiple gestations, suspected growth restriction) 1, 2

Fetal Well-Being Assessment

  • Biophysical Profile (BPP)
    • Evaluates four ultrasound components: fetal breathing movements, body movements, tone, and amniotic fluid volume
    • Score of 8-10 is normal, 6 is equivocal, 4 or less is abnormal 1
  • Modified BPP
    • Combines amniotic fluid assessment with non-stress test (NST) 1
  • Non-stress test (NST)
    • Records fetal heart rate response to movement
    • Typically begins at 32-34 weeks in high-risk pregnancies 1, 2

Doppler Studies

  • Umbilical artery Doppler
    • Evaluates placental function
    • Indicated for suspected fetal growth restriction (FGR) 1
  • Middle cerebral artery Doppler
    • Assesses fetal brain blood flow
    • Used in FGR, multiple gestations (especially monochorionic) 1
  • Ductus venosus Doppler
    • Evaluates fetal cardiac function
    • Abnormal flow associated with poor outcomes in FGR 1

Special Considerations for Multiple Gestations

  • First trimester: Early determination of chorionicity and amnionicity is critical 1
  • Second trimester: Document placental cord insertion for each fetus, especially in monochorionic pregnancies 1
  • Third trimester: More frequent monitoring with growth scans every 3-4 weeks 1
  • Monochorionic twins: Additional surveillance for twin-twin transfusion syndrome (TTTS) starting at 16 weeks 1

Advanced Imaging Techniques

  • 3D/4D ultrasound
    • Helpful for evaluating facial anomalies (clefts) 1
  • Fetal MRI (without contrast)
    • Complementary to ultrasound for evaluating complex anomalies
    • Not used for routine screening
    • Particularly useful for CNS, thoracic, and abdominal anomalies 4, 5, 6

Common Pitfalls and Caveats

  • Timing is critical: Chorionicity determination is most accurate in the first trimester 1
  • Obesity affects imaging: Consider delayed anatomy scan (20-22 weeks) and transvaginal approach in obese patients 1
  • Growth discordance: In multiple gestations, document and monitor closely as it may indicate complications 1
  • False positives: Antenatal testing in low-risk women can lead to iatrogenic prematurity 1
  • Limitations of ultrasound: Some skeletal dysplasias may not be detectable until later in pregnancy or even after birth 1

Remember that while these tests and procedures represent standard practice, the frequency and timing should be adjusted based on specific risk factors and findings throughout pregnancy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prenatal Care for Women with Advanced Maternal Age

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prenatal genetic testing 2: diagnostic tests.

Current opinion in pediatrics, 2022

Research

Evaluation of the prenatally diagnosed mass.

Seminars in fetal & neonatal medicine, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.